Heparin compared with normal saline to maintain patency of permanent double lumen hemodialysis catheters: A randomized controlled trial

Ali Akbar Beigi, Mirhadi Seyed HadiZadeh, Fereshteh Salimi, Hafez Ghaheri, Ali Akbar Beigi, Mirhadi Seyed HadiZadeh, Fereshteh Salimi, Hafez Ghaheri

Abstract

Background: Heparin has long been used to prevent thrombosis in the permanent central venous hemodialysis catheters (PermCath). Other alternatives for heparin with fewer side-effects have recently been considered. We compared normal saline (0.9%) with heparin for flushing PermCath with regards to catheter patency and prevention of heparin complications.

Materials and methods: Chronic kidney disease patients who were candidate of PermCath placement were randomly assigned into two groups of heparin and saline. In the heparin group, the PermCath was flushed with heparin (1000 IU), and in the saline group, it was flushed with saline 0.9%. Patients were followed for 24 hours, and outcomes included catheter thrombosis, maneuver needed to maintain catheter patency, and bleeding from catheter site.

Results: Ninety six patients were included (age = 63.1 ± 11.2 years, 54.2% male). No one experienced catheter thrombosis. Two patient (4.2%) in the heparin and three ones (6.1%) in the saline group required catheter manipulation (P = 0.520). Four patients (8.5%) in the heparin and three ones (6.1%) in the saline group experienced bleeding (P = 0.476); differences between heparin and saline groups in the amount of bleeding (225.0 ± 62.4 vs. 200.0 ± 113.5 cc, P = 0.721) and bleeding time (6.5 ± 1.2 vs. 5.3 ± 1.5 min, P = 0.322) were not significant. In the heparin group, no significant increase was observed in PTT over time; baseline 30.9 ± 3.4, 12 h 31.8 ± 3.4, 24 h 31.2 ± 6.6 (P = 0.628).

Conclusions: Flushing PermCath with normal saline 0.9% is as effective as heparin in maintaining patency of the catheter, while it may reduce the risks associated with heparin.

Keywords: Central venous catheters; hemorrhage; heparin; thrombosis.

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Patients flow diagram

References

    1. NKF-DOQI clinical practice guidelines for vascular access. National Kidney Foundation-Dialysis Outcomes Quality Initiative. Am J Kidney Dis. 1997;30:S150–91.
    1. Trerotola SO. Hemodialysis catheter placement and management. Radiology. 2000;215:651–8.
    1. Liangos O, Gul A, Madias NE, Jaber BL. Long-term management of the tunneled venous catheter. Semin Dial. 2006;19:158–64.
    1. Moran JE, Ash SR. Locking solutions for hemodialysis catheters; heparin and citrate-a position paper by ASDIN. Semin Dial. 2008;21:490–2.
    1. Dreyer G, Lawton P, Jose M. Heparin leak from a hemodialysis catheter causing major bleeding, ultimately leading to transplant rejection and death. Hemodial Int. 2008;12:431–3.
    1. Thomson PC, Morris ST, Mactier RA. The effect of heparinized catheter lock solutions on systemic anticoagulation in hemodialysis patients. Clin Nephrol. 2011;75:212–7.
    1. Yevzlin AS, Sanchez RJ, Hiatt JG, Washington MH, Wakeen M, Hofmann RM, et al. Concentrated heparin lock is associated with major bleeding complications after tunneled hemodialysis catheter placement. Semin Dial. 2007;20:351–4.
    1. Buturovic J, Ponikvar R, Kandus A, Boh M, Klinkmann J, Ivanovich P. Filling hemodialysis catheters in the interdialytic period: Heparin versus citrate versus polygeline: A prospective randomized study. Artif Organs. 1998;22:945–7.
    1. Del CM, Grane N, Llavore M, Quintana S. Heparinized solution vs. saline solution in the maintenance of arterial catheters: A double blind randomized clinical trial. Intensive Care Med. 2008;34:339–43.
    1. Moran J, Sun S, Khababa I, Pedan A, Doss S, Schiller B. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients. Am J Kidney Dis. 2012;59:102–7.
    1. Hughes K, Chang YC, Sedrak J, Torres A. A clinically practical way to estimate surgical blood loss. Dermatol Online J. 2007;13:17.
    1. Pumarola C, Casademont MR, Colomer PM, Cordon BC, Sabench CS, Felez VM, et al. Comparative study of maintenance of patency of triple lumen central venous catheter. Enferm Intensiva. 2007;18:25–35.
    1. Kaneko Y, Iwano M, Yoshida H, Kosuge M, Ito S, Narita I, et al. Natural saline-flush is sufficient to maintain patency of immobilized-urokinase double-lumen catheter used to provide temporary blood access for hemodialysis. Blood Purif. 2004;22:473–9.
    1. Rabe C, Gramann T, Sons X, Berna M, Gonzalez-Carmona MA, Klehr HU, et al. Keeping central venous lines open: A prospective comparison of heparin, vitamin C and sodium chloride sealing solutions in medical patients. Intensive Care Med. 2002;28:1172–6.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren